You Searched For "Eli Lilly" and got 20 results
Sort By:
2 mins read
Eli Lilly's weight-loss drug may prevent diabetes — but there's 1 unanswered question
People with pre-diabetes who took Zepbound or Mounjaro were 94% less likely to develop the disease,…
Hilary Brueck
3 mins read
Weight loss and diabetes drug Tirzepatide will cost Rs 80,000 per month in India
Tirzepatide is set to make its debut in the Indian market under the brand name Mounjaro for the tre…
2 mins read
Eli Lilly just halved the price of its weight-loss drug — declaring war on the booming market of knock-offs
Eli Lilly is now offering cheaper single-dose vials of its wildly popular weight-loss drug Zepbound…
Gabby Landsverk
1 min read
'Unbelievable demand' for weight-loss drugs sends Eli Lilly stock soaring 14% after earnings
"We just see unbelievable demand, and we're not even trying that hard to promote this drug. We're n…
Matthew Fox
1 min read
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says
The anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a r…
George Glover
2 mins read
Another perk of weight-loss drugs? Eli Lilly's Zepbound may alleviate sleep apnea, too
The new class of weight-loss drugs isn't just for diabetes and weight loss. Eli Lilly results from …
Hilary Brueck
5 mins read
5 new weight-loss drugs to watch in the fight for the next Ozempic
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar indu…
Gabby Landsverk
4 mins read
A 38-year-old man says 2 doses of Mounjaro permanently paralyzed his stomach. He's suing Eli Lilly.
Blake has sued Eli Lilly. He says he used Mounjaro to control his blood sugar, and now has life-lon…
Hilary Brueck
2 mins read
Eli Lilly soars 8% after Q1 earnings reveal surging popularity for its Zepbound weight-loss drug
"Demand continues to outstrip even increased supply," Eli Lilly's CFO said of its Zepbound weight l…
Matthew Fox
2 mins read
Weight-loss drugs for first-graders? Eli Lilly is testing Mounjaro shots on kids as young as 6
Both Novo Nordisk and Eli Lilly are trying out their blockbuster weight loss and diabetes drugs, Mo…
Hilary Brueck
2 mins read
FDA just approved Eli Lilly's new weight-loss drug that's cheaper than Wegovy and stronger, too
Eli Lilly's tirzepatide weight-loss drug just got FDA approval. It is cheaper and possibly more eff…
Hilary Brueck
1 min read
Eli Lilly is now worth more than Tesla as the EV maker's stock spirals
Eli Lilly's valuation closed at $595 billion on Thursday, more than Tesla's $581 billion, as the EV…
Aruni Soni
1 min read
Retail traders have been ditching the Magnificent 7 for pharma stocks like Eli Lilly, says JPMorgan
Nividia is still a retail darling, but last week saw individual investors pivot to names like Eli L…
Yuheng Zhan
4 mins read
Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.
A woman who started taking a popular weight loss medication through a clinical trial had to look fo…
Gabby Landsverk
3 mins read
The CEO of pharma giant Eli Lilly shares 3 ways AI could transform his industry
Eli Lilly is investing in hundreds of projects focused on AI, machine learning, and automation.
Yeji Jesse Lee
2 mins read
The next big market for weight-loss drugs: children
Novo Nordisk's weight loss drug, Saxenda, helped children ages six to 11 reduce their body mass ind…
Shubhangi Goel
1 min read
Eli Lilly will be the first trillion-dollar drug company in history, billionaire investor Ken Langone says
Eli Lilly belongs to the small band of pharma stocks that have seen a stellar year, and Langone thi…
Aruni Soni
3 mins read
Eli Lilly rides the weight-loss-drug wave to a new record high, and is now worth more than $700 billion
"We haven't scratched the surface in terms of how big the [GLP-1 weight loss] drugs are going to ge…
Matthew Fox
2 mins read
Eli Lilly stock will surge 29% over the next year with its weight-loss drug on pace to do $60 billion in sales by 2030, BofA says
"We'd argue our forecasts are still conservative, as by 2030, we assume <7% of US adults will be…
Matthew Fox
3 mins read
Eli Lilly stock could soar 140% by 2028 as more people use weight-loss drugs, Goldman says
"GLP-1 based medicines will have a profound effect on the health of individuals, the manufacturers …